potential clinical implications of the latest data on approved and emerging therapies for psoriasis
Published 5 years ago • 108 plays • Length 29:59Download video MP4
Download video MP3
Similar videos
-
32:26
targeting the burden of moderate to severe psoriasis
-
49:11
realizing the potential of tyk2 inhibition to address the burden of psoriasis
-
28:40
evidence on novel cytokine-modulating strategies in the treatment of moderate to severe psoriasis
-
37:32
psoriasis: translating current and emerging therapies into enhanced management strategies
-
25:20
optimizing outcomes throughout the journey of patients with psoriatic arthritis
-
58:51
taking a closer look at psoriatic disease in a new era of patient care
-
37:46
the tyk2 pathway as a novel nonbiologic oral therapeutic option in moderate to severe psoriasis
-
24:56
s2 - episode 1 i psoriatic arthritis: an underdiagnosed disease
-
57:43
npf webinar: new oral treatments
-
33:24
how does 'refractory' skin disease affect psoriasis?
-
58:51
taking aim at the tyk2 pathway in psoriasis
-
3:16
progressing the future of care for people living with psoriasis
-
1:02:09
exploring the latest evidence on new and emerging therapies for migraine prevention
-
39:12
taking a team-based approach to moderate to severe psoriasis in an era of expanding oral treatment
-
1:02:10
fine-tuning the jak/stat pathway in psoriasis
-
58:22
research update: newly approved therapies for psoriasis
-
56:28
overcoming gvhd is the key to better hct outcomes: guidance on managing acute and chronic disease
-
11:08
the psoriasis pipeline: upcoming new systemic drugs | andrew blauvelt, md, mba | united states
-
34:56
clinical assessment and principles of management of psoriasis